Works matching IS 09509232 AND DT 2009 AND VI 28 AND IP 10

Results: 13

Activation of the unliganded estrogen receptor by prolactin in breast cancer cells.
Published in:
Oncogene, 2009, v. 28, n. 10, p. 1298, doi. 10.1038/onc.2008.473
By:
- González, L.;
- Zambrano, A.;
- Lazaro-Trueba, I.;
- Lopéz, E.;
- González, J. J. A.;
- Martín-Pérez, J.;
- Aranda, A.
Publication type:
Article
Role of miR-143 targeting KRAS in colorectal tumorigenesis.
Published in:
Oncogene, 2009, v. 28, n. 10, p. 1385, doi. 10.1038/onc.2008.474
By:
- Chen, X.;
- Guo, X.;
- Zhang, H.;
- Xiang, Y.;
- Chen, J.;
- Yin, Y.;
- Cai, X.;
- Wang, K.;
- Wang, G.;
- Ba, Y.;
- Zhu, L.;
- Wang, J.;
- Yang, R.;
- Zhang, Y.;
- Ren, Z.;
- Zen, K.;
- Zhang, J.;
- Zhang, C.-Y.
Publication type:
Article
Transient receptor potential channel C3 contributes to the progression of human ovarian cancer.
Published in:
Oncogene, 2009, v. 28, n. 10, p. 1320, doi. 10.1038/onc.2008.475
By:
- Yang, S. L.;
- Cao, Q.;
- Zhou, K. C.;
- Feng, Y. J.;
- Wang, Y. Z.
Publication type:
Article
The cell cycle checkpoint kinase CHK2 mediates DNA damage-induced stabilization of TTK/hMps1.
Published in:
Oncogene, 2009, v. 28, n. 10, p. 1366, doi. 10.1038/onc.2008.477
By:
- Yeh, Y.-H.;
- Huang, Y.-F.;
- Lin, T.-Y.;
- Shieh, S.-Y.
Publication type:
Article
Asef2 and Neurabin2 cooperatively regulate actin cytoskeletal organization and are involved in HGF-induced cell migration.
Published in:
Oncogene, 2009, v. 28, n. 10, p. 1357, doi. 10.1038/onc.2008.478
By:
- Sagara, M.;
- Kawasaki, Y.;
- Iemura, S.-i.;
- Natsume, T.;
- Takai, Y.;
- Akiyama, T.
Publication type:
Article
A non-Smad mechanism of fibroblast activation by transforming growth factor-β via c-Abl and Egr-1: selective modulation by imatinib mesylate.
Published in:
Oncogene, 2009, v. 28, n. 10, p. 1285, doi. 10.1038/onc.2008.479
By:
- Bhattacharyya, S.;
- Ishida, W.;
- Wu, M.;
- Wilkes, M.;
- Mori, Y.;
- Hinchcliff, M.;
- Leof, E.;
- Varga, J.
Publication type:
Article
GRIM-19 inhibits v-Src-induced cell motility by interfering with cytoskeletal restructuring.
Published in:
Oncogene, 2009, v. 28, n. 10, p. 1339, doi. 10.1038/onc.2008.480
By:
- Sun, P.;
- Nallar, S. C.;
- Kalakonda, S.;
- Lindner, D. J.;
- Martin, S. S.;
- Kalvakolanu, D. V.
Publication type:
Article
Suppression of breast cancer cell growth by a monoclonal antibody targeting cleavable ErbB4 isoforms.
Published in:
Oncogene, 2009, v. 28, n. 10, p. 1309, doi. 10.1038/onc.2008.481
By:
- Hollmén, M.;
- Määttä, J. A.;
- Bald, L.;
- Sliwkowski, M. X.;
- Elenius, K.
Publication type:
Article
The Tcl1 oncogene defines secondary hair germ cells differentiation at catagen–telogen transition and affects stem-cell marker CD34 expression.
Published in:
Oncogene, 2009, v. 28, n. 10, p. 1329, doi. 10.1038/onc.2008.489
By:
- Ragone, G.;
- Bresin, A.;
- Piermarini, F.;
- Lazzeri, C.;
- Picchio, M. C.;
- Remotti, D.;
- Kang, S.-M.;
- Cooper, M. D.;
- Croce, C. M.;
- Narducci, M. G.;
- Russo, G.
Publication type:
Article
The retinoblastoma gene Rb and its family member p130 suppress lung adenocarcinoma induced by oncogenic K-Ras.
Published in:
Oncogene, 2009, v. 28, n. 10, p. 1393, doi. 10.1038/onc.2008.491
By:
- Ho, V. M.;
- Schaffer, B. E.;
- Karnezis, A. N.;
- Park, K. S.;
- Sage, J.
Publication type:
Article
The protein-tyrosine kinase Syk interacts with TRAF-interacting protein TRIP in breast epithelial cells.
Published in:
Oncogene, 2009, v. 28, n. 10, p. 1348, doi. 10.1038/onc.2008.493
By:
- Zhou, Q.;
- Geahlen, R. L.
Publication type:
Article
Runx3 expression in gastrointestinal tract epithelium: resolving the controversy.
Published in:
Oncogene, 2009, v. 28, n. 10, p. 1379, doi. 10.1038/onc.2008.496
By:
- Ito, K.;
- Inoue, K.-i.;
- Bae, S.-C.;
- Ito, Y.
Publication type:
Article
Lack of p53 induction in fish cells by model chemotherapeutics.
Published in:
2009
By:
- Rau Embry, M.;
- Billiard, S. M.;
- Di Giulio, R. T.
Publication type:
Correction Notice